StreetAlpha
13F holdings · Q3 2026

Nextech Invest

Zurich, V8 · files as Nextech Invest Ltd.
Know the moment Nextech Invest filesYou follow Nextech Invest An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1595430

Nextech Invest reported 18 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (69.9%), PBLS (6.8%) and RLAY (5.5%). Compared with Q2 2026, the fund opened new positions in ATTO, ETRA and AVTX, added to ALMS and SLN, trimmed TYRA and sold out of ARVN.

Latest filing: what Nextech Invest did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
4 new2 added1 trimmed1 sold outBought about $96.8M · sold about $19.4M
New 4
Added 2
Trimmed 1
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$2.2B+5.9% vs last quarter
Stocks held184 new · 1 sold out
Top 5 weight89.8%very concentrated
Turnover5%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 7 qtrsHeld
1
RVMD
Revolution Medicines Inc
$1.6B69.9%7.6MNo change7 of 7
2
PBLS
Parabilis Medicines Inc Com
$151M6.8%4.7MNo change2 of 7
3
RLAY
Relay Therapeutics Inc
$122M5.5%6.8MNo change7 of 7
4
ORIC
Oric Pharmaceuticals Inc
$96.5M4.3%7.2MNo change7 of 7
5
TYRA
Tyra Biosciences Inc
$75.4M3.4%3.4M−106K (−3%)7 of 7
6
ALMS
Alumis Inc
$33.6M1.5%4.6M+1M (+29%)7 of 7
7
ATTO
Attovia Therapeutics Inc
$31.5M1.4%1.8MNew position1 of 7
8
KYMR
Kymera Therapeutics Inc
$31.2M1.4%279KNo change6 of 7
9
ETRA
Electra Therapeutics Inc
$29.7M1.3%2.6MNew position1 of 7
10
ZYME
Zymeworks Inc
$29.5M1.3%1.1MNo change7 of 7
🔒 8 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ARVN
Arvinas Inc
$17.1M1.1M

Reported value

last 7 quarters
$430MQ1 '25
$528MQ2 '25
$657MQ3 '25
$1BQ4 '25
$1.4BQ1 '26
$2.1BQ2 '26
$2.2BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Nextech Invest 13F FAQ

What does Nextech Invest own?

Nextech Invest reported 18 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are RVMD (69.9%), PBLS (6.8%) and RLAY (5.5%). The table above lists every position in the filing (the top 10 without an account).

What did Nextech Invest buy and sell in Q3 2026?

Compared with Q2 2026: 4 new positions, 2 added to, 1 trimmed and 1 sold out. New positions include ATTO, ETRA and AVTX. It sold all of ARVN.

When will Nextech Invest file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Nextech Invest's portfolio worth?

The Q3 2026 filing reports $2.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.